Breaking News
Get 55% Off 0
👀 Ones to watch: The MOST undervalued shares to buy right now
See Undervalued Shares
Close

Euromobiliare Science 4 Life A (0P000146HQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.820 +0.060    +0.96%
22/11 - Closed. Currency in EUR
  • Morningstar Rating:
  • Total Assets: 297.07M
Type:  Fund
Market:  Italy
Issuer:  Euromobiliare Asset Management SGR SpA
ISIN:  IT0005046054 
Asset Class:  Equity
Euromobiliare Science 4 Life A 6.820 +0.060 +0.96%

0P000146HQ Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Euromobiliare Science 4 Life A (0P000146HQ) fund. Our Euromobiliare Science 4 Life A portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 13.700 14.720 1.020
Stocks 51.040 51.040 0.000
Bonds 34.480 47.380 12.900
Convertible 0.780 0.780 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 18.770 16.411
Price to Book 4.131 2.476
Price to Sales 2.583 1.842
Price to Cash Flow 14.980 10.152
Dividend Yield 1.983 2.444
5 Years Earnings Growth 11.736 12.389

Sector Allocation

Name  Net % Category Average
Healthcare 60.510 12.604
Consumer Defensive 10.990 7.852
Industrials 8.690 11.985
Utilities 8.680 3.158
Consumer Cyclical 5.530 12.352
Basic Materials 3.190 6.800
Technology 2.130 20.453
Real Estate 0.280 3.014

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Australasia
  • Developed Markets

Top Holdings

Number of long holdings: 329

Number of short holdings: 19

Name ISIN Weight % Last Change %
  Eli Lilly US5324571083 2.84 755.00 +0.93%
  Novo Nordisk B DK0062498333 2.40 745.4 -0.73%
  UnitedHealth US91324P1021 1.70 605.83 +2.53%
  AstraZeneca GB0009895292 1.54 10,474.0 0.00%
  Merck&Co US58933Y1055 1.45 101.16 +2.00%
  AbbVie US00287Y1091 1.26 177.05 +0.06%
  Nestle CH0038863350 1.11 75.96 -0.05%
  Novartis CH0012005267 1.11 91.93 -1.87%
  Sanofi FR0000120578 1.00 92.79 -0.41%
  Roche Holding Participation CH0012032048 0.98 253.50 -0.31%

Top Equity Funds by Euromobiliare Asset Management SGR SpA

  Name Rating Total Assets YTD% 3Y% 10Y%
  Euromobiliare Flessibile Allocazion 577.31M 8.35 2.31 2.23
  Euromobiliare Azioni Internazionali 449.84M 12.32 3.05 4.59
  LU0284571469 357.87M 19.39 7.08 7.64
  Euromobiliare Progetto 2021 Atto ii 365.8M 6.16 3.17 -
  Euromobiliare TR Flex Value A 365.58M 4.97 -0.10 0.22
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P000146HQ Comments

Write your thoughts about Euromobiliare Science 4 Life A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email